GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neovacs ALNEV.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.09

-5.57%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Neovacs — daily ALNEV

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Neovacs on TradingView ↗
Market value
€17
Last close × shares
Volume
1.9m
Shares, 9 Nov 2026

About Neovacs

Its shares trade on Euronext Paris under the ticker ALNEV.PA. It has been listed since 15 April 2010. In the fiscal year to 31 December 2025, it reported revenue of €161,780 and a net loss of €4.9m. At that date it held total assets of €22.1m and shareholders' equity of €18.0m.

Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2010-04-15. The company specializes in immunotherapy domain and providing treatment for autoimmune and inflammatory diseases. The firm researches and develops Kinoids, drug-candidates which aim to treat disease by including an antibody response in the patient. The firm focuses its development effort on two Kinoids for Crohn’s disease, Rheumatoid Arthritis and lupus disease. Neovacs SA’s portfolio of products includes TNF-Kinoids, IFN-Kinoids and VEGF-Kinoids. The firm operates in France and the United States. In May 2016, the Company signed a joint venture agreement with Stellar Biotechnologies Inc to create Neostell, owned by the Company in 70%.

Figures and description from our data supplier, not checked against the company's own report.

More about Neovacs →

Latest on Neovacs

Our reporting

We have not reported on Neovacs yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Neovacs's ticker?

Neovacs trades as ALNEV.PA on Euronext Paris, under ISIN FR0014010856.

What was Neovacs's last closing price?

0.09 on 9 Nov 2026. The figure is in EUR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.